CUR : Summary for Neuralstem, Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 40 mins

Neuralstem, Inc. (CUR)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.26-0.00 (-1.85%)
As of 1:20 PM EST. Market open.
People also watch:
ATHXCYTXPSTIOSIROPXA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.26
Open0.28
Bid0.25 x 4800
Ask0.26 x 9500
Day's Range0.25 - 0.28
52 Week Range0.22 - 0.35
Volume278,313
Avg. Volume623,350
Market Cap29.85M
Beta1.16
PE Ratio (TTM)-1.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Neuralstem, Inc. : November 28, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Neuralstem, Inc. Here are 5 ETFs with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube22 days ago

    ETFs with exposure to Neuralstem, Inc. : November 14, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Neuralstem, Inc. Here are 5 ETFs with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Neuralstem, Inc. :CUR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
    Capital Cube25 days ago

    Neuralstem, Inc. :CUR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016

    Categories: Yahoo Finance Get free summary analysis Neuralstem, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Neuralstem, Inc. – Titan Pharmaceuticals, Inc., Cytokinetics, Incorporated, Acorda Therapeutics, Inc., Geron Corporation, Albany Molecular Research, Inc., BioTime, Inc., Neurocrine Biosciences, Inc., Aceto Corporation, Charles River Laboratories International, Inc. ... Read more (Read more...)